Business
Telix (ASX:TLX) share price down 4% despite new deal
Biopharma Telix Pharmaceuticals Ltd (ASX: TLX) share price is trading lower this morning, despite the company announcing the completion of its acquisition of Swiss-based company, TheraPharm.
At the same time, the company also announced that TheraPharm has now completed an intellectual property (IP) agreement with the University of Southampton in the United Kingdom.
At the time of writing, the Telix share price is trading at $3.59, down 4.27%.
About the TheraPharm acquisition
Telix advised it has now acquired all of the issued capital of TheraPharm for the final upfront consideration of €10.2 million (A$16.5 million). This was done at a price of $3.75 per share. That deal was first announced in late November.
Telix also…
-
General22 hours agoHomicide detectives investigate death of man in Newcastle unit
-
Noosa News13 hours agoWoman found dead in NSW police station car park feared she was being stalked, father says
-
General12 hours agoHundreds of men march against domestic violence in Alice Springs on Human Rights Day
-
Noosa News19 hours agoMan suffers life-threatening injuries in alleged road rage stabbing in The Gap, Brisbane